Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader represented The Medicines Company, a provider of solutions in serious infectious disease care, acute cardiovascular care and surgery and perioperative care, in its private offering of $402,500,000 convertible Senior Notes due 2023. https://www.cadwalader.com/news/news-release/cadwalader-represents-the-medicines-company-in-its-private-offering-of-402500000-convertible-senior-notes-due-2023